跳至主要内容
临床试验/NCT01921192
NCT01921192Unknown4 期

Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy

University of Catania1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2012年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
160
试验地点
1
主要终点
homocysteine

研究概览

简要总结

Homocysteine, a well-known inducer of vascular endothelial cell damage has been associated with extracellular matrix changes. Many studies demonstrated that high levels of this aminoacid in diabetic patients increases significantly the risk of the development of this pathology. This study has been undertaken to investigate the role of homocysteine and its cofactors (folic acid, vitamin B6 and B12) during the progression of the diabetic retinopathy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diabetic patients with proliferative and non proliferative retinopathy

排除标准

  • Patients with chronic liver disease Patients with kidney disease.

研究组 & 干预措施

Sugar pill

Placebo Comparator

干预措施: Placebo (Drug)

Folic Acid, vit B6 and B12

Active Comparator

干预措施: Folic Acid, vit B6 and B12 (Drug)

结局指标

主要结局

homocysteine

时间窗: 12 months

次要结局

  • folic acid(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mariano Malaguarnera

Associate Professor

University of Catania

研究点 (1)

Loading locations...

相似试验